Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Inhibition of Phytohemagglutinin-Induced In Vitro Lymphocyte Transformation by Serum From Patients With Carcinoma

Identifieur interne : 003B50 ( Main/Exploration ); précédent : 003B49; suivant : 003B51

Inhibition of Phytohemagglutinin-Induced In Vitro Lymphocyte Transformation by Serum From Patients With Carcinoma

Auteurs : W. Frederick Sample [États-Unis] ; Harold R. Gertner [États-Unis] ; Paul B. Chretien [États-Unis]

Source :

RBID : ISTEX:5ADC6269F4C423CBA0285413ECEFEA762957CB1B

Abstract

The in vitro reactivity in autologous serum of lymphocytes from 100 normal persons and 120 cancer patients was determined by quantitation of phytohemagglutinin-induced tritiated thymidine incorporation. With the data from the study of normal lymphocytes, an age-correlated range of normal lymphocyte reactivity in autologous serum was derived. With this used as the criterion, the sera of 9 patients with carcinoma, whose lymphocytes in autologous serum had markedly low reactivity, were isolated and assayed for a suppressive effect on normal lymphocyte reactivity. A pool of AB sera, in which the reactivity of normal lymphocytes did not differ from their reactivity in autologous serum, was used as a constant homologous reference serum. The reactivity of normal lymphocytes in serum from each of the 9 cancer patients was lower than their reactivity in the homologous pooled AB serum. The data demonstrate an inhibitor of normal lymphocyte reactivity in the sera of patients with carcinoma.

Url:
DOI: 10.1093/jnci/46.6.1291


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Inhibition of Phytohemagglutinin-Induced In Vitro Lymphocyte Transformation by Serum From Patients With Carcinoma</title>
<author>
<name sortKey="Sample, W Frederick" sort="Sample, W Frederick" uniqKey="Sample W" first="W. Frederick" last="Sample">W. Frederick Sample</name>
</author>
<author>
<name sortKey="Gertner, Harold R" sort="Gertner, Harold R" uniqKey="Gertner H" first="Harold R." last="Gertner">Harold R. Gertner</name>
</author>
<author>
<name sortKey="Chretien, Paul B" sort="Chretien, Paul B" uniqKey="Chretien P" first="Paul B." last="Chretien">Paul B. Chretien</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:5ADC6269F4C423CBA0285413ECEFEA762957CB1B</idno>
<date when="1971" year="1971">1971</date>
<idno type="doi">10.1093/jnci/46.6.1291</idno>
<idno type="url">https://api.istex.fr/ark:/67375/HXZ-PZW7NRH9-C/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002A23</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002A23</idno>
<idno type="wicri:Area/Istex/Curation">002A23</idno>
<idno type="wicri:Area/Istex/Checkpoint">002890</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002890</idno>
<idno type="wicri:doubleKey">0027-8874:1971:Sample W:inhibition:of:phytohemagglutinin</idno>
<idno type="wicri:Area/Main/Merge">003C30</idno>
<idno type="wicri:Area/Main/Curation">003B50</idno>
<idno type="wicri:Area/Main/Exploration">003B50</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Inhibition of Phytohemagglutinin-Induced
<hi rend="italic">In Vitro</hi>
Lymphocyte Transformation by Serum From Patients With Carcinoma</title>
<author>
<name sortKey="Sample, W Frederick" sort="Sample, W Frederick" uniqKey="Sample W" first="W. Frederick" last="Sample">W. Frederick Sample</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Surgery Branch, National Cancer Institute, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Gertner, Harold R" sort="Gertner, Harold R" uniqKey="Gertner H" first="Harold R." last="Gertner">Harold R. Gertner</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Surgery Branch, National Cancer Institute, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Chretien, Paul B" sort="Chretien, Paul B" uniqKey="Chretien P" first="Paul B." last="Chretien">Paul B. Chretien</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Surgery Branch, National Cancer Institute, Bethesda</wicri:cityArea>
</affiliation>
<affiliation></affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Journal of the National Cancer Institute</title>
<title level="j" type="abbrev">Journal of the National Cancer Institute</title>
<idno type="ISSN">0027-8874</idno>
<idno type="eISSN">1460-2105</idno>
<imprint>
<publisher>Oxford University Press</publisher>
<date when="1971-06">1971</date>
<biblScope unit="vol">46</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="1291">1291</biblScope>
<biblScope unit="page" to="1297">1297</biblScope>
</imprint>
<idno type="ISSN">0027-8874</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0027-8874</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">The in vitro reactivity in autologous serum of lymphocytes from 100 normal persons and 120 cancer patients was determined by quantitation of phytohemagglutinin-induced tritiated thymidine incorporation. With the data from the study of normal lymphocytes, an age-correlated range of normal lymphocyte reactivity in autologous serum was derived. With this used as the criterion, the sera of 9 patients with carcinoma, whose lymphocytes in autologous serum had markedly low reactivity, were isolated and assayed for a suppressive effect on normal lymphocyte reactivity. A pool of AB sera, in which the reactivity of normal lymphocytes did not differ from their reactivity in autologous serum, was used as a constant homologous reference serum. The reactivity of normal lymphocytes in serum from each of the 9 cancer patients was lower than their reactivity in the homologous pooled AB serum. The data demonstrate an inhibitor of normal lymphocyte reactivity in the sera of patients with carcinoma.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Maryland</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Maryland">
<name sortKey="Sample, W Frederick" sort="Sample, W Frederick" uniqKey="Sample W" first="W. Frederick" last="Sample">W. Frederick Sample</name>
</region>
<name sortKey="Chretien, Paul B" sort="Chretien, Paul B" uniqKey="Chretien P" first="Paul B." last="Chretien">Paul B. Chretien</name>
<name sortKey="Gertner, Harold R" sort="Gertner, Harold R" uniqKey="Gertner H" first="Harold R." last="Gertner">Harold R. Gertner</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003B50 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003B50 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:5ADC6269F4C423CBA0285413ECEFEA762957CB1B
   |texte=   Inhibition of Phytohemagglutinin-Induced In Vitro Lymphocyte Transformation by Serum From Patients With Carcinoma
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021